Brief: Apontis EBITDA By End-April Up At EUR 1.6 Million

Apontis Pharma AG

20/05/2021 06:34

May 20 (Reuters) - APONTIS PHARMA AG  APPHG.DE :
    * STRONG REVENUES AND EARNINGS GROWTH WITH SINGLE PILLS
CONTINUES
IN THE FIRST FOUR MONTHS OF 2021
    * REVENUE GROWTH OF 18% TO EUR 15.1 MILLION IN FIRST FOUR
MONTHS
FROM JANUARY TO END OF APRIL 2021
    * EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND
AMORTIZATION
(EBITDA) INCREASED TO EUR 1.6 MILLION IN FIRST FOUR MONTHS

Source text for Eikon:  ID:nEQ5Zq4z0a 
Further company coverage:  APPHG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))